Polymorphic Stability and Enhanced Drug Release of Dabigatran Etexilate Mesylate in Mesoporous Silica-Based Liquisolid Systems- Formulation and In Vitro Evaluation
Journal of Pharmaceutical Innovation · 2025-04 · 20 (2)
DOI: 10.1007/s12247-025-09986-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Innovation, online erschienen am 14.04.2025. Verfasst von Sayani Bhattacharyya und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bhattacharyya, S., Gurung, M., & Sivakumar, K. (2025). Polymorphic Stability and Enhanced Drug Release of Dabigatran Etexilate Mesylate in Mesoporous Silica-Based Liquisolid Systems- Formulation and In Vitro Evaluation. Journal of Pharmaceutical Innovation, 20(2). https://doi.org/10.1007/s12247-025-09986-3
Vancouver
Bhattacharyya S, Gurung M, Sivakumar K. Polymorphic Stability and Enhanced Drug Release of Dabigatran Etexilate Mesylate in Mesoporous Silica-Based Liquisolid Systems- Formulation and In Vitro Evaluation. Journal of Pharmaceutical Innovation. 2025;20(2). doi:10.1007/s12247-025-09986-3
BibTeX
@article{Bhattacharyya2025,
author = {Bhattacharyya, Sayani and Gurung, Manish and Sivakumar, Kogileshwari},
title = {Polymorphic Stability and Enhanced Drug Release of Dabigatran Etexilate Mesylate in Mesoporous Silica-Based Liquisolid Systems- Formulation and In Vitro Evaluation},
journal = {Journal of Pharmaceutical Innovation},
year = {2025},
volume = {20},
number = {2},
doi = {10.1007/s12247-025-09986-3}
}
EUVIMED